The concept of platinum sensitivity could be applied to recurrent cervical cancer: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group

Purpose This study aimed at evaluating the applicability of the concept of platinum sensitivity to recurrent cervical cancer. Methods The clinical information of patients with recurrent cervical cancer, who were initially treated with platinum-based chemotherapy and received second-line platinum-bas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer chemotherapy and pharmacology 2017-10, Vol.80 (4), p.697-705
Hauptverfasser: Takekuma, Munetaka, Mori, Keita, Iida, Tetsuji, Kurihara, Kazuko, Saitou, Motoaki, Tokunaga, Hideki, Kawana, Kei, Ikeda, Masae, Satoh, Toyomi, Saito, Toshiaki, Miyagi, Etsuko, Nagai, Yutaka, Furusawa, Akiko, Kawano, Yoshiaki, Kawano, Kouichiro, Tabata, Tsutomu, Ota, Yukinobu, Hayase, Ryoji, Mikami, Mikio, Sugiyama, Toru
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose This study aimed at evaluating the applicability of the concept of platinum sensitivity to recurrent cervical cancer. Methods The clinical information of patients with recurrent cervical cancer, who were initially treated with platinum-based chemotherapy and received second-line platinum-based chemotherapy at the time of recurrence between January 2008 and December 2012, was retrospectively reviewed. Results A total of 677 patients from 71 medical centers were analyzed. The median overall survival (OS) for patients with platinum-free interval (PFI) of
ISSN:0344-5704
1432-0843
DOI:10.1007/s00280-017-3402-x